Last update 02 May 2024

Xiamen Encheng Pharmaceutical Co Ltd

2006|
Fujian Sheng, China

Overview

Basic Info

Introduction
The pharmaceutical company Xiamen Earnest Pharma Co., Ltd. was established on December 22, 2006, as a wholly-owned subsidiary of the Earnest Group. The parent group, Earnest, constitutes a diversified corporate entity that integrates the complete medical supply chain, precision medicine, cultural media, and investment activities.

Tags

Neoplasms
Mouth and Tooth Diseases
Otorhinolaryngologic Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2

Pipeline

Pipeline Snapshot as of 17 May 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
NDA/BLA
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lansoprazole
( Proton pump )
-
NDA/BLA
SOCC-2
( ATPase )
Zollinger-Ellison Syndrome
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free